Rajiv Mahadevan

Rajiv Mahadevan is the co-founder and CEO of Attune Neurosciences, a San Francisco neurotechnology company building what it calls the world's first wearable, non-invasive ultrasound system for deep brain therapy. A UC Berkeley molecular biologist turned Stanford MBA, he spent two decades inside biotech and precision-medicine companies - 23andMe, Novo Nordisk, and his own venture Applied Immunology, which was acquired by Precision Medicine Group - before turning his attention to the skull. Attune's headband-shaped device aims low-intensity focused ultrasound at deep brain structures with MRI-guided precision, and it is backed by venture investors, the NIH, and the U.S. Special Operations Command.